Synopsys has been assigned a Zacks Rank #1 (Strong Buy), indicating potential near-term outperformance. The consensus earnings estimate for the current quarter stands at $3.68 per share, reflecting 8.6% year-over-year growth, while full-year estimates of $14.75 and $17.18 for the current and next fiscal years imply increases of 14.3% and 16.4%, respectively. Revenue projections show a 40.3% jump to $2.44 billion for the current quarter, with annual estimates of $9.69 billion and $10.68 billion. The stock has declined 8.7% over the past month, compared with a 1.4% drop in the S&P 500 and a 20.3% loss in its industry. Synopsys topped consensus EPS and revenue estimates in three of the last four quarters, though it receives a Value Style Score of F, signaling a premium valuation relative to peers.
Synopsys IncZacks Rank #1 Strong Buy and upward earnings estimate revisions signal positive analyst sentiment and expected outperformance.